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Abstract: In the present study, mycelial biomass of Ganoderma lucidum strains was produced in mushroom complete 
media under optimized culture conditions of temperature, pH, agitation and the fruiting bodies were raised on wheat 
straw supplemented with 5 per cent rice bran. Maximum biomass (16.39 mg ml-1) was recorded in strain GL-3 and 
minimum (10.99 mg ml-1) was observed in strain GL-1 after 28 days of incubation period. Maximum biological efficiency of 
13.1 per cent was obtained in 57 days in GL-2 strain. Moreover, weight of fruiting bodies was highest (91 g bag-1) in 
5 per cent wheat bran supplemented bags in strain GL-2. Polysaccharides were extracted, characterized and  
analysed. The maximum yield of polysaccharides was obtained from fruiting bodies (30.06- 63.70%), followed by 
mycelial biomass (7.61- 21.32%) and culture filtrates (0.86- 2.86%). Non-reducing sugars were the main fraction of 
sugars which constituted 69.82- 70.39 per cent in fruiting body extracted polysaccharides, 62.08- 83.39 per cent in 
biomass and  59.75- 77.54 per cent in crude extracts. The extracts from fruiting bodies and biomass of G. lucidum 
strains also exhibited antibacterial effect against some pathogenic bacteria, Staphylococcus sp. and Enterobacter 
sp. The present study clearly indicated that variations existed among G. lucidum strains with respect to the production of 
bioactive molecules, yield and antimicrobial activity. Bioactive components from G. lucidum strains are promising 
antimicrobial agents that can be harnessed as potent antimicrobial toxicant. 
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INTRODUCTION 
Ganoderma lucidum is a medicinal fungus in Polyporaceae. 
The fungus is saprobic in nature, growing alone or in 
groups on decaying hardwood logs. It is known as 
‘lingzhi’ and was first indexed in Shen Nong’s Materia 
Medica (206 BC-8 AD) as a longevity-promoting and 
tonic herb of the non-toxic superior class (Zhu et al., 
2007). It has been used in traditional Chinese medicine 
for more than 2000 years to prevent and treat diseases 
including hepatitis, chronic bronchitis, gastritis, tumor 
growth and immunological disorders (Lin and Zhang, 
2004). The chemical components of G. lucidum extracted 
from the fruiting body, mycelium, or spores includes 
polysaccharides, flavonoids, alkaloids, amino acids, 
steroids, oligosaccharides, proteins and mannitol 
(Zjawiony, 2004). Among these components, G. lucidum 
polysaccharides and triterpenes have been identified as 
the major bioactive components, showing multiple 
pharmacological effects, such as immunomodulation, 
anti-oxidation, hepatoprotection, anti-proliferation, and 
anti-angiogenesis (Xu et al., 2011). Each fraction of 
polysaccharides and triterpenes has more than 100 
molecules that have been isolated, most of these are 
potent immunomodulators and/or antioxidants and are 
also chemopreventive and tumoricidal (Gao et al., 
2002 and 2004). The lingzhi isolated polysaccharides 
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are macromolecules, having a molecular weight range 
from 4 × 105 to 1 × 106 Dalton in the primary structure. 
Most of these polysaccharides are extractable with hot 
water, salt solutions, alkali solutions, and dimethyl 
sulfoxide solution. The purified molecules are less 
soluble in water and become more soluble in alkali 
(Gao et al., 2004). The extracts of G. lucidum have 
also been reported to be active against Bacillus subtilis 
and Pseudomonas syringes which are plant pathogen 
(Ofodile et al., 2005). Traditionally, bioactive components 
have been extracted from fruiting bodies. However, 
mycelial biomass production forms a promising future 
platform for fully standardized production of safe 
mushroom based dietary supplements containing these 
bioactive components. The present investigation elucidates 
interesting chemical compounds extracted, purified 
and identified from fruiting body, mycelial biomass 
and culture filtrate of G. lucidum strains and their 
evaluation against some pathogenic isolates of bacteria. 
MATERIALS AND METHODS 
Mycelial biomass and fruiting bodies: The mycelial 
biomass of G. lucidum strains (GL-1, GL-2 and GL-3) 
was raised in the mushroom complete medium 
(Glucose-20g, Peptone- 2.0g, Yeast extract- 2.0, 
KH2PO4- 0.5g, K2HPO4- 1.0g, MgSO4.7H2O- 0.5g)  
under optimized conditions of temperature (300C), pH 
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(5.0) and agitation (100 rpm) after 28 days. Fruiting 
bodies were also raised on sterilized wheat straw  
supplemented rice bran (5% w/w) substrate. Fruit bodies 
were harvested after maturity. Biological efficiency 
(B.E.) was calculated using the following formula 
(Chang and Miles, 2004). 
Extraction and analysis of polysaccharide: The 
polysaccharides were extracted from the mycelial  
biomass, culture filtrate of three G. lucidum strains 
(GL-1, GL-2 and GL-3) and fruiting bodies of GL-1 
and GL-2 strains using method by Yap and Ng, (2001). 
The mycelial biomass raised in MCM for all the three 
strains was filtered through Whatmann no.1 filter  
paper and washed with distilled water. About 15 g of 
the mycelium was homogenised in a tissue homogeniser, 
transferred to a 500 ml round bottomed flask and 100 
ml of distilled water was added to it. The samples in 
the round bottomed flasks fitted with condensers, were 
refluxed on a hot plate at 100ºC for 10 hrs. The  
refluxed samples were cooled and filtered through 
Whatmann filter paper no.1.The filtrates obtained were 
used for the extraction of polysaccharides, while the 
residues left were discarded. The filtrates were concentrated 
to about 1/10th of the original volume by evaporating 
water from them with the use of distillation condensers 
and were cooled.  
To the concentrated extracts, the equal amount of pre-chilled 
ethanol (4ºC) was added after cooling to room tem-
perature and the samples were kept at -20˚C for 2 hrs 
in order to get complete precipitation of polysaccharides. 
After precipitation, the samples were centrifuged in a 
cooling centrifuge (Remi) at 4ºC for 20 min at 6000 
rpm. The residue so obtained was the first fraction of 
polysaccharides which was collected in a pre-weighed 
glass vial and stored at room temperature. The supernatant 
left after centrifugation was used for the extraction of 
second fraction of polysaccharides. Again equal volume 
of ethanol was added to the supernatant, kept at -20˚C 
for overnight. Next day, the suspension was centrifuged 
at 4ºC in a cooling centrifuge at 6000 rpm for 20 min. 
The residue obtained was collected as the second fraction 
of polysaccharides in glass vials and stored at room 
temperature while the supernatant left after centrifugation 
was discarded. The crude extracts left after filtration of 
mycelial biomass were as such concentrated without 
refluxing for 10 hrs and precipitated repeatedly with 
chilled ethanol so as to separate the polysaccharides 
from them. Similar procedure was followed for the 
extraction of polysaccharides from the fruiting bodies 
of GL-1 and GL-2 strains of G. lucidum.  
The percentage yield obtained in all the samples was 
then calculated by the following formula: 
The polysaccharides were quantitatively analysed by 
estimating the amount of polysaccharides obtained 
after extraction process. The estimation was done for 
total sugars by Dubois et al. (1956) as well as reducing 
sugars by Miller (1959). 
Antimicrobial activity: The antibacterial activity of 
various extracts of G. lucidum strains was determined 
against the bacterial cultures of Staphylococcus sp., 
Salmonella sp., Enterobacter sp., Pseudomonas sp., 
Klebsiella sp. and E. coli procured from Sawai Mansingh 
General Hospital and Medical College, Jaipur, India. 
The cultures were maintained in sterile nutrient agar 
slant at 4 ˚C.  
Preparation of mushroom extracts: Two types of 
extracts (Methanolic and aqueous extract) were used 
for the assessment of antimicrobial activity of the 
mushroom. The mycelium of all the three strains of G. 
lucidum was used for preparing two kinds of extracts. 
GL-3 strain produced no fruiting bodies hence methanolic 
and aqueous extracts were prepared for the fruiting 
bodies of GL-1 and GL-2 strains. 
Methanolic extracts: The methanolic extracts of 
mycelium and fruit bodies were prepared using 
methanol as an extracting solvent according to the 
methodology of Kalsi (2002). 5 g of fresh mycelium of 
each strain of G. lucidum were refluxed with 50ml of 
methanol at 40oC on water bath for 4 hrs.  The contents 
were filtered through pre-sterilized Whatmann no.1 
filter papers and cooled. The extracts obtained were 
left overnight at room temperature to evaporate the 
methanol and were collected in pre-sterilized screw 
capped glass vials. Similarly, 5 g of dried and powdered 
fruit body of GL-1 and GL-2 strains were used to prepare 
the methanolic extract in a similar manner and stored 
at 4oC. 
Aqueous extract: The hot water extracts were prepared 
using mycelium and fruit body. 5 g of fresh mycelium 
of all the three strains of G. lucidum were heated with 
100ml of distilled water on a boiling water bath at 100º 
C for 8 hrs. The contents were filtered through pre-sterilized 
Whatmann no.1 filter papers and cooled to room 
temperature. The extracts were collected in pre-sterilized 
screw capped vials and stored at 4ºC in refrigerator 
until use.  The aqueous extract of the fruit body of GL 
-1 and GL-2 strains were also prepared in a similar 
way using five g of dried, powdered sample and then 
stored. 
Antimicrobial activity of methanolic and aqueous  
extracts was evaluated by the filter paper disc and 
spectrophotometeric method. Experiment was set up in 
three replications. Plates and liquid medium were  
incubated at 37°C for 24 to 48 hrs. 
RESULTS AND DISCUSSION 
Liquid culture studies for biomass production: 
Three strains of G. lucidum, GL-1, GL-2 and GL-3 
were grown in mushroom complete medium adjusted 
at pH 6.0 value. Results indicated the increase in biomass 
yields with increase in incubation up to 28 days. Maximum 
biomass yield production values were recorded in 
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B.E. (%)       = 
Fresh wt of mushrooms 
× 100 
Dry wt of substrate 
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strain GL-3 (16.39 mg ml-1), GL-2 (12.74 mg ml-1) and 
the least for GL-1 (10.99 mg ml-1) after 28 days of 
incubation period. Rate of biomass production was 
more from 14-21 days of incubation (Table 1). Varied 
biomass production values have been recorded by  
different workers depending upon the medium used, 
initial pH, incubation period and type of cultivation 
system used. Kim et al. (2002) found that mushroom 
complete medium supported maximum biomass  
production in case of G. lucidum as compared to yeast 
malt extract (YM) and potato malt peptone (PMP). The 
dry cell weight after 15 days of incubation was 6.24 g l
-1 for G. lucidum.  In case of YM and PMP media, 
these values were 5.65 g l-1 and 4.20 g l-1 respectively 
after 15 days of incubation. Lee et al. (2007) obtained 
17.8 g l-1, 19.4 g l-1 and 18.9 g l-1 cell masses on the 
media containing glucose, fructose and maltose. 
Shivani (2008) had observed the same trend of biomass 
production using four strains of GL-1, GL-2, GL-3 and 
GL-4 after 21 days of incubation. Zapata et al. (2012) 
obtained mycelial biomass (23.49 ± 0.37 g l-1);  
extracellular polysaccharides (2.72 ± 0.11 g l-1);  
intracellular polysaccharides (2.22 ± 0.06 g l-1); ganoderic 
acids production (299.67 ± 11.63 mg l-1) in G. lucidum 
on optimal medium composition defined as (g l-1): 50 
of barley flour, 0.2 of KH2PO4, 0.1 of MgSO4.7H2O, 
and 1 NH4Cl.  Fraga et al. (2014) obtained maximum 
mycelial biomass and exopolysaccharide purity at low 
peptone level (1.65g l-1) in G. lucidum. However, they 
found maximum exopolysaccharide production at 
higher amount of peptone (4.80 g l-1). 
Yield evaluation of G. lucidum strains: The effect of 
supplementation of wheat bran revealed that maximum 
biological efficiency of 10.3% was obtained at 5 per 
cent level in GL-1. Moreover, 5 per cent wheat bran 
supplementation resulted in more fruiting bodies (72 g 
bag-1) and mycelia spread was also fast (53 days).  
Improvement in yield at higher rate of supplementation 
(15 % and 20 %) was not significant at 5 per cent level 
of significance. In case of GL-2, yield data followed 
the same trend as in case of GL-1 supplementation of 
wheat bran @ 5- 15 per cent support better growth and 
fruiting bodies production than at 20 per cent. Weight 
of fruiting bodies was highest (91 g bag-1) in 5 per cent 
wheat bran supplemented bags as compared to others 
(Table 2). GL-3 strain was found non-productive on 
wheat straw as no fruiting body of this strain was  
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Strain 
No. 
Incubation  period (Days) 
Dry biomass (mg g-1) 
7 14 21 28 
GL-1 6.17 7.17 8.80 10.99 
GL-2 4.94 8.31 10.19 12.74 
GL-3 10.69 11.93 15.38 16.39 
CD at 5% 1.22 1.34 1.53 1.28 
Average of 5 replicates; Medium: Mushroom complete 
medium; Incubation temperature: 30± 2˚C 
Table 1. Biomass production of G. lucidum strains. 
Treatments GL-1 strain GL-2 strain 
Supplement 
level (%) 
DSR 
NFB 
Bag-1 
WFB(g) 
Bag-1 
BE (%) DSR 
NFB  
Bag-1 
WFB(g)  
Bag-1 
BE (%) 
Control 63 3 20 2.9 61 4 26 3.7 
5 53 8 72 10.3 53 6 91 13.0 
10 55 5 56 8.0 56 2 30 4.3 
15 64 4 45 6.4 62 6 60 8.6 
20 60 3 22 3.1 67 3 26 3.7 
CD at 5%       6.78       0.77 
DSR= Days for spawn run, NFB= No. of fruiting body, WFB= Weight of fruiting body; Dry wt. of wheat straw/ Bag:  350g; 
No. of replicate bags:  15; *Strain GL-3 produced no fruiting bodies 
Table 2. Effect of wheat bran supplementation on the yield of GL-1 and GL-2 strains.  
Table 3. Polysaccharide, reducing and non reducing sugar contents in G. lucidum strains. 
Sample Strain 
Polysaccharide 
yield (%) 
Reducing 
sugars (%) 
Non reducing 
Sugars (%) 
Biomass 
GL-1 21.40 37.92 62.08 
GL-2 16.00 25.45 74.55 
GL-3 7.67 16.61 83.39 
Crude 
Extract 
GL-1 0.86 67.72 32.28 
GL-2 2.87 40.25 59.75 
GL-3 2.53 22.46 77.54 
Fruiting 
Body 
GL-1 30.07 30.18 69.82 
GL-2 63.70 29.61 70.39 
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obtained. 
Chen (1999) reported that rice or wheat bran addition 
was essential for the successful cultivation of G. lucidum. 
Addition of rice bran or wheat bran to the substrate 
takes care of the requirement of thiamine, which is 
very essential for the mycelial growth and reproduction of 
G. lucidum. Stamets (2000) reported that over supplementation 
with rice bran, beyond 15 per cent of the dry mass of 
the substrate inhibits fruit body development. Mishra 
and Singh (2006) reported that wheat bran supplemented 
with 5 per cent rice bran gave significantly higher B.E. 
(15-17 %) at 5 per cent level of significance than sawdust 
as substrate which gave only 5-14 per cent B.E. 
Shivani (2008) obtained maximum biological efficiency 
of G. lucidum with rice bran (10.7 %) at 5 per cent as 
compared to wheat bran (10.0 %) and further increase 
in the rate of supplementation resulted in decrease in 
biological efficiency which corroborate the present 
findings. Supplementation of both the brans @ 5-15 
per cent supported better growth and fruiting body 
production than at 20 per cent. The best combinations 
for high yield (142.44 g/kg) and biological efficiency 
(18.68%) of G. lucidum were obtained by Azizi et al. 
(2012) in a combination of poplar sawdust with 5% 
malt extract and 10% wheat bran. The highest mycelia 
growth rate (10.6 mm/day) was obtained in a combination 
of beech sawdust with 2.5% malt extract and 10% 
wheat bran. Ueitele et al. (2014) concluded that corn 
cobs have the potential to be used as alternate substrate 
for Ganoderma mushroom cultivation in Namibia and 
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Fig. 1. Spectro-photometric method to determine quantitative antibacterial activity of extracts of three strains of G. lucidum after 24 hrs. 
Fig. 2. Spectro-photometric method to determine quantitative antibacterial activity of extracts of three strains of G. lucidum after 48 hrs. 
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obtained a higher biological efficiency (5.32%) as 
compared to saw dust (0.05%).   
Polysaccharides, reducing sugars and non- reducing 
sugars: The polysaccharides obtained from fruiting 
bodies and mycelial biomass represents endopolysaccharides 
and those extracted in the culture filtrate were  
exopolysaccharides. The maximum yield of polysaccharides 
was obtained from fruiting bodies (30.06- 63.70%), 
followed by mycelial biomass (7.61- 21.32%) and culture 
filtrates (0.86- 2.86%). Endopolysaccharides were 
maximum in the fruit bodies of GL-2 strain (63.70%) 
and in the mycelial biomass of GL-1 strain (21.40%). 
The exo-polysaccharide production was recorded highest 
in GL-2 strain (2.87%) and minimum in GL-1 strain 
(0.86%) as given in Table 3. Cui et al. (2006) reported 
107.34 mg g-1, 83.13 mg g-1, 105.45 mg g-1 and 98.25 
mg g-1 of total polysaccharides in G. lucidum extract, 
by conventional vacuum drying; freeze drying, microwave 
vacuum and conventional vacuum drying on dry 
weight basis. 
Non-reducing sugars were the main fraction in all the 
cases. Maximum non-reducing sugars were observed 
in GL-3 strain in biomass and crude extract. However, 
the non-reducing sugars were found maximum in the 
fruit body of GL-2 strain. Correspondingly, the 
amounts of reducing sugars were lesser in extracted 
polysaccharides from fruiting bodies, mycelial biomass 
and culture filtrates. Reducing sugars were 29.61 
- 30.18 per cent in fruiting body extracted polysaccharides, 
followed by crude extracts (22.46- 67.72%) and minimum in 
biomass polysaccharides (16.61- 37.92%). Lee et al. 
(2007) reported that endopolysaccharides obtained 
from G. lucidum were containing 76% glucose, 8% 
galactose, 9% mannose and 7% xylose, whereas in 
case of exopolysaccharides, glucose was 81%, galactose 
7%, mannose 12% and xylose was in trace elements. 
They also isolated a galactose rich extracellular (GLP-2) 
from submerged culture broth of G. lucidum, which 
was composed of galactose, mannose, glucose, arabinose 
and rhamnose in the molar ratios 103: 17: 12: 10:3. 
Narkprasom et al. (2013) optimized the submerged 
fermentation conditions for Ganoderma tsugae by  
using Plackett Burman Design and obtained maximum 
extracellular polysaccharide content (415 mg l-1) under 
optimized culture conditions (31.031 g l-1 maltose, 
14.055 g l−1 skim milk and an initial pH of 7.12). 
Antibacterial potential of Ganoderma extracts on 
solid and liquid media: The antibacterial potential of 
the methanolic and aqueous extracts of G. lucidum 
strains against six pathogenic bacteria was studied by 
filter-paper disc and spectrophotometric methods for 
24 and 48 hrs. The results of filter paper disc method 
are presented in Table 4.  
Antimicrobial activity of methanolic extracts of biomass 
and fruit body of all the strains showed effective zone 
of inhibition as compared to aqueous extracts. The 
maximum antibacterial activity of methanolic extracts 
of biomass and fruit body of G. lucidum strains was 
found against Staphylococcus sp. based on zone of 
inhibition and minimum against Klebsiella and E. coli. 
The maximum inhibition zone ranging from 2.2- 2.5 
cm was recorded for Staphylococcus. Aqueous extracts 
of biomass and fruit body also showed maximum inhibition 
of growth of Staphylococcus sp. and minimum of 
Pseudomonas sp. The maximum inhibition zone was 
ranging from 1.8- 2.0 cm for Staphylococcus. 
In case of spectrophotometric method, increase in  
incubation period (24 to 48 hrs) resulted in decrease in 
antibacterial potential as manifested by increase of 
optical density (OD) Methanolic extracts were again 
found to be more effective against pathogenic bacteria 
as compared to aqueous extracts. These extracts were 
inhibitory to all the bacterial spp. except Salmonella 
sp. which was least inhibited by these extracts. Overall 
these extracts were having variable responses towards 
pathogenic bacteria, and these variations were also 
observed to different strains of G. lucidum (Figs. 1 and 2).  
The results of the present study are somewhat corroborated 
by the findings of Kamble et al. (2011) who reported 
that methanol, acetone, chloroform and aqueous  
extracts of G. lucidum biomass to be more effective 
against Staphylococcus aureus, Bacillus subtilis, and 
Corynebacterium diphtheriae, whereas these extracts 
were least inhibitory against E. coli, Proteus mirabilis, 
K. pneumoniae, Salmonella typhii and Pseudomonas 
P18. Bhosle et al. (2010) regarded G. lucidum as a 
broad spectrum antibiotic which were highly effective 
against both Gram positive as well as Gram negative 
bacteria. Singh et al. (2014) reported acetone and 
methanolic extract of G. lucidum fruiting body possessed 
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Bacteria Chloram-
phenicol 
(10 mg ml-1) 
Clear zone diameter (cm) 
Methanolic extracts Aqueous extracts 
A B C D E A B C D E 
Staphylococcus sp. 3.1 2.4 2.5 2.3 2.5 2.2 1.9 1.9 2.0 1.7 1.7 
Salmonella sp. 2.3 1.7 1.3 1.3 1.2 1.2 1.1 0.8 1.2 1.1 1.3 
Pseudomonas sp. 2.9 1.8 1.5 1.7 1.5 1.9 1.2 1.2 0.7 0.6 0.3 
Enterobacter sp. 2.1 2.2 2.5 2.5 1.9 1.4 1.7 1.5 1.3 1.1 1.2 
Klebsiella sp. 1.9 1.7 1.1 1.3 1.6 1.5 1.4 1.3 1.0 1.5 1.6 
E. coli 2.5 2.0 1.5 1.4 0.9 0.9 0.5 0.7 1.2 1.0 0.5 
A: GL-1 Biomass, B: GL-2 Biomass, C: GL-3 Biomass, D: GL-1 Fruiting body, E: GL-2 Fruiting body; Incubation Time: 24 
hrs; Incubation Temperature: 37° C 
Table 4. Antibacterial activity of the extracts of strains of G. lucidum by filter paper disc method. 
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strong antimicrobial activity and considered as antimicrobial 
agent which can be used in the development of new 
drug for the different bacterial and fungal pathogenesis 
in humans. 
Conclusion 
Three indigenous strains of Ganoderma lucidum were 
screened for biomass, polysaccharide production and 
biological efficiency during cultivation indicated that 
strain GL-3 to be the most potential strain producing 
for maximum biomass production in liquid culture, 
whereas strain GL-1 and GL-2 can be exploited for 
cultivation of this fungus. The extracted polysaccharides 
showed potential antimicrobial activity against bacterial 
pathogens. Thus, bioactive components from G. lucidum 
strains are promising antimicrobial agents that can be 
harnessed as potent antimicrobial toxicant.    
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